Australia, N.Z. Stocks: Austal, ResMed, Fisher & Paykel Health
Stock Chart for Austal Ltd (ASB)
The following were among the most active shares in the market today. Stock symbols are in parentheses after company names.
Gold producers: Gold futures for June delivery gained 0.5 percent to settle at $1,523.30 an ounce on the Comex in New York, the highest closing price for a most-active contract since May 3.
Newcrest Mining Ltd. (NCM) , Australia’s biggest gold producer, advanced 0.3 percent to A$38.15. Alacer Gold Corp. (AQG AU) surged 8.2 percent to A$9.22.
Austal Ltd. (ASB) plunged 12 percent to A$2.55 after the shipbuilder released a full-year profit forecast.
Campbell Brothers Ltd. (CPB) declined 0.7 percent to A$44.63. The manufacturer of cleaning agents was cut to “neutral” from “overweight” at JPMorgan Chase & Co. and to “hold” from “buy” at Royal Bank of Scotland Group Plc.
Carsales.com.au Ltd. (CRZ) , Australia’s most popular automotive website, rose 1.1 percent to A$4.74 after announcing a share buyback.
ConnectEast Group (CEU) dropped 1 percent to 48 Australian cents. The operator of the EastLink toll road in Australia’s Victoria state was downgraded to “neutral” at Macquarie Research. The stock was previously rated “outperform,” according to data compiled by Bloomberg.
Elders Ltd. (ELD) declined 2.2 percent to 45 Australian cents. The Australian supplier of rural services was downgraded to “underperform” from “speculative buy” with a 12-month price target at A$0.40 a share by John Welsh, an analyst at BBY Limited.
Pharmaxis Ltd. (PXS) tumbled 72 percent to 83 Australian cents. The company, which develops products for chronic respiratory and autoimmune diseases, said the Committee for Medicinal Products for Human Use indicated it would vote against the approval of Bronchitol.
ResMed Inc. (RMD) gained 1.7 percent to A$2.99 after the maker of machines to overcome night-time breathing disorders had its stock rating raised to “buy” from “neutral” at Merrill Lynch.
Treasury Wine Estates Ltd. (TWE AU) advanced 1.6 percent to A$3.26 after the wine distributor was rated “buy” in new coverage at Merrill Lynch.
Fisher & Paykel Healthcare Corp. (FPH NZ) fell 2.9 percent to NZ$3.02, a New Zealand maker of breathing masks and hospital equipment, reported a 27 percent decline in full-year profit on a stronger currency and one-time tax expenses.
To contact the reporter on this story: Shani Raja in Sydney at email@example.com.
To contact the editors responsible for this story: Nick Gentle at firstname.lastname@example.org.
Bloomberg reserves the right to edit or remove comments but is under no obligation to do so, or to explain individual moderation decisions.